TLR4 and Hepatic steatosis: As an important innate immune pattern recognition receptor (PRR), toll-like receptor 4 (TLR4) has been found to be upregulated in both NAFLD patients and animal models and is counted for the progression of hepatic steatosis, inflammation, and fibrosis [8–10].